Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 29.45B | 27.58B | 24.62B | 31.32B | 28.58B |
Gross Profit | 2.55B | 2.43B | 2.23B | 3.27B | 3.36B |
EBITDA | 1.17B | 1.14B | 921.00M | 2.00B | 2.10B |
Net Income | 921.00M | 685.00M | 523.00M | 1.25B | 1.32B |
Balance Sheet | |||||
Total Assets | 25.30B | 27.39B | 23.78B | 25.41B | 23.60B |
Cash, Cash Equivalents and Short-Term Investments | 4.48B | 9.57B | 9.43B | 9.18B | 7.73B |
Total Debt | 831.00M | 827.00M | 831.00M | 821.00M | 929.00M |
Total Liabilities | 10.40B | 13.03B | 9.72B | 11.45B | 10.45B |
Stockholders Equity | 14.90B | 14.36B | 14.06B | 13.97B | 13.14B |
Cash Flow | |||||
Free Cash Flow | -4.45B | 617.00M | 711.00M | 2.02B | -325.00M |
Operating Cash Flow | -4.23B | 680.00M | 799.00M | 2.10B | -228.00M |
Investing Cash Flow | -407.00M | -70.00M | -80.00M | -78.00M | -74.00M |
Financing Cash Flow | -466.00M | -468.00M | -468.00M | -569.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥9.93B | 11.66 | 4.79% | 5.27% | -26.42% | ||
82 Outperform | ¥8.36B | 5.02 | 0.26% | 15.97% | 3.62% | ||
81 Outperform | ¥11.14B | 4.20 | 4.61% | 11.12% | 29.82% | ||
72 Outperform | ¥9.89B | 10.74 | 4.65% | 6.79% | 34.45% | ||
71 Outperform | ¥9.08B | 5.30 | 0.32% | 21.36% | 55.82% | ||
63 Neutral | ¥8.71B | 3.98 | 2.65% | 18.22% | 430.92% | ||
58 Neutral | HK$13.89B | 4.44 | -3.01% | 7.32% | 3.67% | -54.16% |